临床医学工程
臨床醫學工程
림상의학공정
CLINICAL MEDICAL ENGINEERING
2014年
5期
585-586
,共2页
双歧三联活菌片%蒙脱石散%小儿急性腹泻%临床治疗
雙歧三聯活菌片%矇脫石散%小兒急性腹瀉%臨床治療
쌍기삼련활균편%몽탈석산%소인급성복사%림상치료
Bifid triple viable bacterial tablets%Montmorillonite powder%Infantile acute diarrhea%Clinical treatment
目的:探讨双歧三联活菌片联合蒙脱石散治疗小儿急性腹泻的有效性与安全性。方法将150例急性腹泻的患儿随机分为观察组和对照组,每组75例。两组患儿予以基础治疗的同时,对照组给予蒙脱石散、观察组给予双歧三联活菌片联合蒙脱石散治疗,对两组患儿的疗效及并发症进行比较分析。结果观察组的总有效率明显高于对照组,差异有统计学意义(孕<0.05),观察组的体温恢复正常时间、呕吐缓解时间、腹痛缓解时间及排便恢复正常时间均明显少于对照组,差异分别有统计学意义(孕<0.05)。结论基础治疗与双歧三联活菌片联合蒙脱石散治疗小儿腹泻,能明显提高疗效,无严重不良反应发生。
目的:探討雙歧三聯活菌片聯閤矇脫石散治療小兒急性腹瀉的有效性與安全性。方法將150例急性腹瀉的患兒隨機分為觀察組和對照組,每組75例。兩組患兒予以基礎治療的同時,對照組給予矇脫石散、觀察組給予雙歧三聯活菌片聯閤矇脫石散治療,對兩組患兒的療效及併髮癥進行比較分析。結果觀察組的總有效率明顯高于對照組,差異有統計學意義(孕<0.05),觀察組的體溫恢複正常時間、嘔吐緩解時間、腹痛緩解時間及排便恢複正常時間均明顯少于對照組,差異分彆有統計學意義(孕<0.05)。結論基礎治療與雙歧三聯活菌片聯閤矇脫石散治療小兒腹瀉,能明顯提高療效,無嚴重不良反應髮生。
목적:탐토쌍기삼련활균편연합몽탈석산치료소인급성복사적유효성여안전성。방법장150례급성복사적환인수궤분위관찰조화대조조,매조75례。량조환인여이기출치료적동시,대조조급여몽탈석산、관찰조급여쌍기삼련활균편연합몽탈석산치료,대량조환인적료효급병발증진행비교분석。결과관찰조적총유효솔명현고우대조조,차이유통계학의의(잉<0.05),관찰조적체온회복정상시간、구토완해시간、복통완해시간급배편회복정상시간균명현소우대조조,차이분별유통계학의의(잉<0.05)。결론기출치료여쌍기삼련활균편연합몽탈석산치료소인복사,능명현제고료효,무엄중불량반응발생。
Objective To explore the effectiveness and safety of bifid triple viable bacterial tablets combined with montmorillonite powder in the treatment of infantile acute diarrhea. Methods One hundred and fifty cases of children with acute diarrhea were randomly divided into observation group and control group, with 75 cases in each group. Both groups received basic treatment, in addition, patients in the control group were treated with montmorillonite powder, and patients in the observation group were treated with bifid triple viable bacterial tablets combined with montmorillonite powder. The clinical effect and complications were analyzed and compared between the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). The time of body temperature returned to normal, vomiting remission, abdominal pain remission and bowel recovery to normal time of the observation group was significantly less than that of the control group (P<0.05). Conclusions On the basis of basic therapy, bifid triple viable bacterial tablets combined with montmorillonite powder can effectively improve curative effect in the treatment of infantile acute diarrhea, and has no sever adverse reactions.